|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/62 | (2006.01) |
| A61K 38/46 | (2006.01) | ||
| C12N 9/16 | (2006.01) | ||
| A61P 19/08 | (2006.01) |
| (11) | Number of the document | 3404102 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18173111.8 |
| Date of filing the European patent application | 2005-04-21 | |
| (97) | Date of publication of the European application | 2018-11-21 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-11 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 56382804 P | 2004-04-21 | US | |
| 59034704 P | 2004-07-23 | US | |
| 61498404 P | 2004-10-04 | US |
| (72) |
Crine, Philippe , CA
Boileau, Guy , CA
Lemire, Isabelle , CA
Loisel, Thomas P. , CA
|
| (73) |
Alexion Pharmaceuticals, Inc. ,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (54) | BONE DELIVERY CONJUGATES AND METHOD OF USING SAME TO TARGET PROTEINS TO BONE |
| BONE DELIVERY CONJUGATES AND METHOD OF USING SAME TO TARGET PROTEINS TO BONE |